Through a combination of cytokines array, quantitative PCR, and ELISA assay, we confirmed that FGF2 was the key factor that facilitated the development of chemoresistance of prostate cancer cells co-cultured with endothelial cells. Here, FGF2 is linked to prostate cancer.